Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Zenalux Research Partnership with Roswell Park Cancer Institute Deploys Zenascope™ PC1 in PDTZenalux and Roswell collaborating through Research Partnership program…
“The excellent technical support, ease-of-use, and speed of the real-time spectroscopy system makes it ideal for clinical use,” said Gal Shafirstein, Professor of Oncology, Departments of Cell Stress Biology and Head and Neck Surgery at Roswell Park Cancer Institute. “The Zenascope’s real time monitoring of critical biological endpoints may be a key enabler in translating our PDT technology into widespread clinical use.” The first step in the research collaboration will be to demonstrate the ability to carry out real-time measurement of drug concentration in addition to blood concentration and oxygen saturation. The ability to quickly customize the Zenascope PC1 to include the measurement of drug concentration is just one example of how the Zenalux system can be easily customized to measure biomarkers of choice. “We are very excited to expand our Research Partnership program to include the Roswell Park Cancer Institute,” said Jesko von Windheim, CEO of Zenalux. “It’ The Zenascope™ PC1, an ultraviolet- Current applications for the Zenascope system include accelerating feedback in drug discovery; breast tumor margin assessment; assessment of response to cancer therapy; and screening and diagnostic applications in breast, cervical, and head and neck cancer. Zenascope is currently designated for investigational purposes only. Interested organizations can contact Zenalux at info@zenalux.com or 919-794-5757 x504. About Zenalux Biomedical, Inc. Zenalux Biomedical is a biomedical diagnostics start-up company that is developing novel biophotonic- ### Keywords: Zenalux, Roswell Park Cancer Institute, Zenascope™, PC1, biomedical, biophotonics, pre-clinical, in vivo, ex vivo, photodynamic therapy, PDT, cancer detection, response to therapy End
Account Email Address Account Phone Number Disclaimer Report Abuse
|